Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Free University of Brussels

Headquarters: Brussels, Belgium
Year Founded: 1834
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Aug 11, 2023
Discovery & Translation

Bacteria to detect tumors; plus Netris’ mAb to block EMT in cancer and more

BioCentury’s roundup of translational innovations
BioCentury | Sep 21, 2022
Management Tracks

New CEOs at Scholar Rock, Neuway, NeuVasQ and ProLynx

Plus Serono’s Maria Rivas joins Pfizer, and updates from 
BioCentury | Feb 18, 2022
Discovery & Translation

Engineered Wnt ligand restores BBB; plus Codiak, Autotac and more

BioCentury’s roundup of translational news
BioCentury | Oct 11, 2018
Distillery Therapeutics

Cancer

BioCentury | Nov 28, 2017
Distillery Techniques

Biomarkers

BioCentury | May 2, 2013
Distillery Therapeutics

Indication: Various

BioCentury | Oct 25, 2012
Distillery Therapeutics

Indication: Hematology

BioCentury | Oct 18, 2012
Distillery Therapeutics

Indication: Endocrine/metabolic disease

Items per page:
1 - 10 of 23